558 Federal Register / Vol. 76, No. 3 / Wednesday, January 5, 2011 / Notices 

in the North American alumina wear 

tile markets. 

Pursuant to the proposed Consent 

Agreement, for a period of ten years 

Keystone must obtain Commission 

approval prior to acquiring, directly or 

indirectly, Saint-Gobain’s alumina wear 

tile assets. These assets primarily 

include the Latrobe facility, but also 

include assets of Saint-Gobain’s alumina 

wear tile business or any interest in 

assets owned or controlled by SaintGobain relating to the research, 

development, marketing, and sale 

anywhere in the world of alumina wear 

tile produced and manufactured in 

North America. 

Pursuant to the proposed Consent 

Agreement, for a period of five years 

Saint-Gobain must provide advance 

written notification to the Commission 

before selling all or substantially all of 

its North American alumina wear tile 

business to any person other than an 

affiliate. Saint-Gobain also must provide 

prior notice to the Commission before 

closing or ceasing operations at the 

Latrobe facility, subject to certain 

exceptions for maintenance, 

construction of improvements, and the 

like, and for involuntary closures due to 

force majeure, health and safety 

emergencies, and other such events. 

As part of ensuring the continued 

viability of Saint-Gobain’s alumina wear 

tile business, Keystone, pursuant to the 

proposed Consent Agreement, must 

comply with all terms of alumina wear 

tile business agreements between 

Keystone and Saint-Gobain. One of 

these agreements is a supply agreement 

for certain types of standard alumina 

tile produced at the Vinhedo, Brazil 

facility (‘‘Vinhedo tile) that Keystone 

will acquire from Saint-Gobain. This 

supply agreement gives Saint-Gobain 

access to the alumina wear tile from the 

Vinhedo facility for a limited interim 

period, by which time Saint-Gobain will 

be required to find another source for 

the Vinhedo tile or produce it 

internally. 

VI. Opportunity for Public Comment 

The proposed Consent Agreement has 

been placed on the public record for 

thirty days for receipt of comments by 

interested persons. Comments received 

during this period will become part of 

the public record. After thirty days, the 

Commission will review the comments 

received, and decide whether to 

withdraw from the proposed Consent 

Agreement, modify it, or make it final. 

By accepting the proposed Consent 

Agreement subject to final approval, the 

Commission anticipates that the 

competitive problems alleged in the 

complaint will be resolved. The purpose 

of this analysis is to inform and invite 

public comment on the proposed 

Consent Agreement, including the 

proposed remedy, and to aid the 

Commission in its determination of 

whether to make the proposed Consent 

Agreement final. This analysis is not 

intended to constitute an official 

interpretation of the proposed Consent 

Agreement, nor to modify the terms of 

the proposed Consent Agreement in any 

way. 

By direction of the Commission. 

Richard C. Donohue, 

Acting Secretary. 

[FR Doc. 2010–33245 Filed 1–4–11; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Assistant Secretary for 

Planning and Evaluation; Medicare 

Program; Meeting of the Technical 

Advisory Panel on Medicare Trustee 

Reports 

AGENCY: Assistant Secretary for 

Planning and Evaluation, HHS. 

ACTION: Notice of meeting. 

SUMMARY: This notice announces public 

meetings of the Technical Advisory 

Panel on Medicare Trustee Reports 

(Panel). Notice of these meetings is 

given under the Federal Advisory 

Committee Act (5 U.S.C. App. 2, section 

10(a)(1) and (a)(2)). The Panel will 

discuss the long-term rate of change in 

health spending and may make 

recommendations to the Medicare 

Trustees on how the Trustees might 

more accurately estimate health 

spending in the long run. The Panel’s 

discussion is expected to be very 

technical in nature and will focus on the 

actuarial and economic assumptions 

and methods by which Trustees might 

more accurately measure health 

spending. Although panelists are not 

limited in the topics they may discuss, 

the Panel is not expected to discuss or 

recommend changes in current or future 

Medicare provider payment rates or 

coverage policy. 

Meeting Dates: January 10, 2011, 

9 a.m. to 6 p.m. and January 28, 2011, 

9:30 a.m.–5 p.m. e.t. 

ADDRESSES: The meetings will be held at 

HHS headquarters at 200 Independence 

Ave., SW., Washington, DC 20201, 

Room 705A. 

Comments: The meeting will allocate 

time on the agenda to hear public 

comments. In lieu of oral comments, 

formal written comments may be 

submitted for the record to Donald T. 

Oellerich, OASPE, 200 Independence 

Ave., SW., 20201, Room 405F. Those 

submitting written comments should 

identify themselves and any relevant 

organizational affiliations. 

FOR FURTHER INFORMATION CONTACT: 

Donald T Oellerich (202) 690–8410, 

Don.oellerich@hhs.gov. Note: Although 

the meeting is open to the public, 

procedures governing security 

procedures and the entrance to Federal 

buildings may change without notice. 

Those wishing to attend the meeting 

must call or e-mail Dr. Oellerich by 

Thursday January 6, 2011 for the 

meeting on January 10 and Tuesday 

January 25, 2011 for the meeting on 

January 28, so that their name may be 

put on a list of expected attendees and 

forwarded to the security officers at 

HHS Headquarters. 

SUPPLEMENTARY INFORMATION: 

Topics of the Meeting: The Panel is 

specifically charged with discussing and 

possibly making recommendations to 

the Medicare Trustees on how the 

Trustees might more accurately estimate 

the long term rate of health spending in 

the United States. The discussion is 

expected to focus on highly technical 

aspects of estimation involving 

economics and actuarial science. 

Panelists are not restricted, however, in 

the topics that they choose to discuss. 

Procedure and Agenda: This meeting 

is open to the public. The Panel will 

likely hear presentations from Medicare 

public trustees are on issues they wish 

the panel to address. This may be 

followed by HHS staff presentations 

regarding long range growth. After any 

presentations, the Panel will deliberate 

openly on the topic. Interested persons 

may observe the deliberations, but the 

Panel will not hear public comments 

during this time. The Panel will also 

allow an open public session for any 

attendee to address issues specific to the 

topic. 

Authority: 42 U.S.C. 217a; Section 222 of 

the Public Health Services Act, as amended. 

The panel is governed by provisions of 

Public Law 92–463, as amended (5 U.S.C. 

Appendix 2), which sets forth standards for 

the formation and use of advisory 

committees. 

Dated: December 28, 2010. 

Sherry Glied, 

Assistant Secretary for Planning and 

Evaluation. 

[FR Doc. 2010–33296 Filed 1–4–11; 8:45 am] 

BILLING CODE P 


jlentini on DSKJ8SOYB1PROD with NOTICES